Neoadjuvant Enoblituzumab for Localized Prostate Cancer Subsequently Treated With Curative-Intent Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Nature Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Neoadjuvant enoblituzumab in localized prostate cancer: a single-arm, phase 2 trial
Nat. Med. 2023 Apr 01;29(4)888-897, E Shenderov, AM De Marzo, TL Lotan, H Wang, S Chan, SJ Lim, H Ji, ME Allaf, C Chapman, PA Moore, F Chen, K Sorg, AM White, SE Church, B Hudson, PA Fields, S Hu, SR Denmeade, KJ Pienta, CP Pavlovich, AE Ross, CG Drake, DM Pardoll, ES AntonarakisFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.